Produktanfrage
FAQ
How should a RABV-G reagent be selected?
Match strain, host expression, tag or label, and the intended binding, antibody-titer, or functional readout.
Can the listed protein be used to measure neutralization?
It is an antigen reagent; use an appropriate neutralization assay to measure functional virus-blocking activity.
Why does RABV-G conformation matter in binding assays?
RABV-G is structurally flexible. Changes in conformation can alter epitope exposure and antibody recognition.
Which antibody-titer kits are available?
Available options include mouse and rat anti-RABV glycoprotein antibody IgG-titer ELISA kits.
What antibody reagents are included?
Available options include monoclonal antibodies against rabies glycoprotein G in mouse or human IgG formats.
Which fluorescent RABV-G format is available?
GLN-RF5E3 is FITC-labeled CVS-11 glycoprotein G with a His tag.
Which recombinant RABV-G protein is available?
RAG-V55H5 is a His-tagged glycoprotein G from rabies virus strain CVS-11, produced in insect cells.
What role does rabies virus glycoprotein G play?
RABV-G is a surface antigen involved in viral entry and a target of neutralizing antibodies.
Asset Licensing Opportunity
Resources
Klinische Arzneimittelinformation
| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| VT-1021 | VT-1021 | Phase 3 Clinical | Vigeo Therapeutics Inc | Solid tumours; Glioblastoma | Details |
| TAX-2 | TAX-2; AP-01; AP-02 | Phase 2 Clinical | Centre National De La Recherche Scientifique (Cnrs), University of Reims | Solid tumours; Thrombosis | Details |
Customer Reviews